U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Sweet Springs Valley Water Co., Inc. - 513227 - 10/04/2021
  1. Warning Letters

CLOSEOUT LETTER

Sweet Springs Valley Water Co., Inc. MARCS-CMS 513227 —

Delivery Method:
VIA Electronic Mail
Product:
Food & Beverages

Recipient:
Recipient Name
Mabel Y. Cox
Recipient Title
Facility Manager
Sweet Springs Valley Water Co., Inc.

1598 Rowan Rd.
Gap Mills, WV 24941-8715
United States

sweetsprings@frontier.com
Issuing Office:
Baltimore District Office

United States


Dear Mabel Cox,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter with CMS#513227, dated March 7, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations, or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Daniel W. Johnson
Compliance Officer
HAF Division East 2, Philadelphia Office
Office p hone: 215.717.3746
e-mail: Daniel.Johnson@fda.hhs.gov

Cc (via email):
Randy F. Pack, Program Division Director, District Director (randy.pack@fda.hhs.gov)
Robin M. Rivers, Director, Compliance Branch (Robin.Rivers@fda.hhs.gov)
Martin J. Guardia, Director, Investigations Branch (martin.guardia@fda.hhs.gov)
Karen S. Anthony, Supervisory Consumer Safety Officer (karen.anthony@fda.hhs.gov)

 
Back to Top